Intranasal Esketamine-dexmedetomidine Combination and Postpartum Depression | MicrobiomeTrials← Back to trialsNCT07639099
Intranasal Esketamine-dexmedetomidine Combination and Postpartum Depression
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-06Est. Completion: 2029-10
Enrollment target: 164 participants Locations- Peking University First Hospital, Beijing, Beijing Municipality, China
Other microbiome trials you might be interested in
Congenital Antithrombin Deficiency
The goal of this study is to assess the incidence of the composite of thrombotic events (TEs) and thromboembolic events …
Washington D.C., United StatesEst. completion Dec 1, 2026
Total Dose of Bupivacaine Administered During Labor
The study aimed to determine the effects of using varied doses of DEX on the concentration of bupivacaine injected for e…
Shebeen El Kom, EgyptEst. completion Oct 1, 2026